Answers are grounded in this paper and cite their sources.
On the basis of the potent antiviral activity of acyclovir and ganciclovir, selenoacyclovir (2a) and selenoganciclovir (2b) were designed based on bioisoteric rationale and synthesized via the diselenide 7 as the key intermediate. Compound 2a exhibited potent anti-HSV-1 and -2 activities while 2b exerted moderate anti-HCMV activity, indicating that these nucleosides can serve as a novel template for the development of new antiviral agents.
No takes yet. Share an insight, caveat, or question.
Sahu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: